Abstract:Fenamate NSAIDs are inhibitors of cyclooxygenases, antagonists of non-selective cation channels, subtype-selective modulators of GABA(A) receptors, weak inhibitors of glutamate receptors and activators of some potassium channels. These pharmacological actions are all implicated in the pathogenesis of ischemic stroke. The aim of this study was to investigate the hypothesis that the fenamate, mefenamic acid, is neuroprotective in an in vitro and in vivo model of stroke. Embryonic rat hippocampal neurons were cultured and maintained for up to 14 days in vitro. At 9 or 14 days, cells were exposed to glutamate (5microM) or glutamate (5microM) plus mefenamic acid (10-100microM) or the control agent, MK-801 (10microM) for 10min. 24h later, cell death was determined by measuring lactate dehydrogenase (LDH) levels in the culture media. In vivo, male Wistar rats (300-350g) were subjected to 2h middle cerebral artery occlusion (MCAO) followed by 24h reperfusion. Animals received either a single i.v. dose of MFA (10mg/kg or 30mg/kg), or MK-801 (2mg/kg) or saline prior to MCAO or, four equal doses of MFA (20mg/kg) at 1h intervals beginning 1h prior to MCAO. Ischemic damage was then assessed 24h after MCAO. In vitro, mefenamic acid (10-100microM) and MK-801 (10microM) significantly reduced glutamate-evoked cell death compared with control cultures. In vivo, MFA (20mg/kgx4) significantly reduced infarct volume, total ischemic brain damage and edema by 53% (p< or =0.02), 41% (p< or =0.002) and 45% (p< or =0.002) respectively. Furthermore, mefenamic acid reduced cerebral edema when measured as a function of brain water content. MK-801 was also neuroprotective against MCAO brain injury. This study demonstrates a significant neuroprotective effect by a fenamate NSAID against glutamate-induced cell toxicity, in vitro and against ischemic stroke in vivo. Further experiments are currently addressing the mechanism(s) of this neuroprotection.

Mefenamic acid bi-directionally modulates the transient outward K+ current in rat cerebellar granule cells.

Flufenamic acid bi-directionally modulates the transient outward K(+) current in rat cerebellar granule cells.

Flufenamic Acid Bi-Directionally Modulates the Transient Outward K<sup>+</sup> Current in Rat Cerebellar Granule Cells

Diclofenac, a nonsteroidal anti-inflammatory drug, activates the transient outward K+ current in rat cerebellar granule cells.

Dual effects of mefenamic acid on the IKs molecular complex

Ibuprofen modulates tetrodotoxin-resistant persistent Na+ currents at acidic pH in rat trigeminal ganglion neurons

Evidence for neuroprotection by the fenamate NSAID, mefenamic acid

The non-steroidal anti-inflammatory drug, diclofenac, inhibits Na+ current in rat myoblasts

Inhibition of acid-sensing ion channels in articular chondrocytes by amiloride attenuates articular cartilage destruction in rats with adjuvant arthritis

Reversible Inhibition of Intracellular Calcium Influx Through NMDA Receptors by Imidazoline I(2) Receptor Antagonists.

Modulation of muscle rNaV1.4 Na+ channel isoform by arachidonic acid and its non-metabolized analog.

Exposure To Extremely Low-Frequency Electromagnetic Fields Modulates Na+ Currents In Rat Cerebellar Granule Cells Through Increase Of Aa/Pge(2) And Ep Receptor-Mediated Camp/Pka Pathway

Inflammasome, Inflammation, Infection and Mefenamic Acid

Elevation of Intracellular Ca2+ Modulates A-currents in Rat Cerebellar Granule Neurons.

Mecamylamine Prevents Neuronal Apoptosis Induced by Glutamate and Low Potassium Via Differential Anticholinergic-Independent Mechanisms

Modulation of the glycine response by Ca <sup>2+</sup> ‐permeable AMPA receptors in rat spinal neurones

Modulation of the glycine response by Ca2+-permeable AMPA receptors in rat spinal neurones

M-channels modulate network excitatory activity induced by 4-aminopyridine in immature rat substantia gelatinosa in vitro

Moricizine Prevents Atrial Fibrillation by Late Sodium Current Inhibition in Atrial Myocytes.

The general anesthetic etomidate and fenamate mefenamic acid oppositely affect GABAAR and GlyR: a structural explanation

Monoamine NMDA receptor channel blockers inhibit and potentiate native and recombinant proton-gated ion channels